Simultaneous determination of sulpiride and mebeverine by HPLC method using fluorescence detection: Application to real human plasma

Chemistry Central Journal

Volumn 6, Issue 1, 2012, Pages

  Walash, Mohamed I ^a   Kh Sharaf El din, Mohie M ^a   El enany, Nahed M ^a   Eid, Manal I ^a   Shalan, Shereen M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

HPLC fluorimetric detection; Mebeverine; Mebeverine metabolite (veratic acid); Pharmaceutical preparations and human plasma; Sulpiride

Indexed keywords

EID: 84857024584     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-6-13     Document Type: Article

References (12)

1. Sweetman SC. Martindale: The complete Drug Reference 2007, 119-692. The Pharmaceutical Press, London, 35.
2. British Pharmacopoeia Commission British Pharmacopoeia 2007 2007, The stationary office, UK, London, (electronic version), British Pharmacopoeia Commission.
3. Zayed SI. Simultaneous determination of mebeverine hydrochloride and sulpiride using the first derivatives of ratio spectra and chemometric methods. Anal Sci 2005, 21:985-989. 10.2116/analsci.21.985, 16122173.
4. El Walily AF, El Gindy A, Bedair MF. Application of first-derivative UV-spectrophotometry, TLC-densitometry and liquid chromatography for the simultaneous determination of mebeverine hydrochloride and sulpiride. J Pharm Biomed Anal 1999, 21:535-548. 10.1016/S0731-7085(99)00176-4, 10701420.
5. Walash M, Sharaf El-Din M, El-Enany N, Eid M, Shalan S. First Derivative synchronous fluorescence spectroscopy for the simultaneous determination of sulpiride and mebeverine hydrochloride in their combined tablets and application to real human plasma. J Fluoresc 2010, 20:1275-1285. 10.1007/s10895-010-0679-0, 20607372.
6. Naguib IA, Abdelkawy M. Development and validation of stability indicating HPLC and HPTLC methods for determination of sulpiride and mebeverine hydrochloride in combination. Eur J Med Chem 2010, 45:3719-3725. 10.1016/j.ejmech.2010.05.021, 20538381.
7. Naguib IA, Darwish HW. Improved partial least squares models for stability-indicating analysis of mebeverine and sulpiride mixtures in pharmaceutical preparation: A comparative study. Drug test anal 2011,
8. Abdelal A, El-Enany N, Belal FF. Simultaneous determination of sulpiride and its alkaline degradation product by second derivative synchronous fluorescence spectroscopy. Talanta 2009, 80:880-888. 10.1016/j.talanta.2009.08.007, 19836568.
9. Miller JC, Miller JN. Statistics and Chemometrics for Analytical Chemistry 2005, 256. Prince Hall, England, 5.
10. ICH Harmonized Tripartite Guideline, Validation of analytical procedures: Text and methodology, Q2(R1). Current Step 4 Version, Parent Guidlines ON Methodology Dated November 6, 1996, Incorporated in November 2005., http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf
11. Dickinson RG, Baker PV, Franklin ME, Hooper WD. Facile hydrolysis of mebeverine in vitro and in vivo: Negligible circulating concentrations of the drug after oral administration. J Pharm Sci 1991, 80:952-957. 10.1002/jps.2600801010, 1784004.
12. Stockis A, Guelen PJ, de Vos D. Identification of mebeverine acid as the main circulating metabolite of mebeverine in man. J Pharm Biomed Anal 2002, 29:335-340. 10.1016/S0731-7085(02)00023-7, 12062694.